The pathogenesis of pterygium: current concepts and their therapeutic implications

Jeanie Chui1, Nick Di Girolamo, Denis Wakefield

  • 1Inflammatory Diseases Research Unit, Department of Pathology, University of New South Wales, and Department of Ophthalmology, University of New South Wales at Prince of Wales Hospital, Sydney, Australia.

The Ocular Surface
|February 12, 2008
PubMed

Insights

Pterygium, an eye condition linked to UV exposure, involves abnormal ocular surface growth. This review details UV-induced signaling pathways, genetic factors, and emerging therapeutic strategies for pterygium.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Genetics

Background:

  • Pterygium is an ocular surface disease linked to chronic ultraviolet (UV) radiation exposure.
  • Its pathogenesis involves complex processes including proliferation, inflammation, fibrosis, and extracellular matrix remodeling.
  • While not fully understood, significant advancements have been made in elucidating the underlying mechanisms.

Purpose of the Study:

  • To provide an updated review of the signaling pathways activated by UV light in pterygium pathogenesis.
  • To discuss recent genetic studies concerning hereditary factors in pterygium development.
  • To explore the potential roles of epithelial-mesenchymal transition, bone marrow progenitor cells, and neuronal signals.

Main Methods:

  • Literature review focusing on UV-induced signaling pathways.
  • Analysis of recent genetic association studies.
  • Synthesis of information on cellular and molecular mechanisms contributing to pterygium.

Main Results:

  • UV light activates specific signaling pathways that induce mediators responsible for pterygium growth.
  • Genetic factors and hereditary predispositions play a role in pterygium development.
  • Epithelial mesenchymal transition, bone marrow progenitor cells, and neuronal signals are implicated in pterygium pathogenesis.

Conclusions:

  • Understanding UV-induced signaling and genetic factors is crucial for comprehending pterygium.
  • Emerging insights into cellular mechanisms offer new perspectives on disease development.
  • Therapeutic strategies can be informed by the mechanisms that drive pterygium progression.

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...